This topic contains a solution. Click here to go to the answer

Author Question: For a monopolist that does not price discriminate, economic profit is maximized in the short run at ... (Read 93 times)

rosent76

  • Hero Member
  • *****
  • Posts: 516
For a monopolist that does not price discriminate, economic profit is maximized in the short run at a price of 140 . Marginal revenue at that output level is
 a. equal to 140
  b. greater than 140
  c. less than 140
  d. less than marginal cost
  e. greater than average revenue

Question 2

Which of the following is true when regulators require a natural monopolist to set price equal to marginal cost?
 a. This policy results in a less than socially optimal allocation of resources.
  b. The marginal cost of producing the last unit sold exceeds the consumers' marginal value for that last unit.
  c. The monopolist will face recurring losses unless a subsidy is provided.
  d. The monopolist will earn a normal profit.
  e. The monopolist will earn more than a fair return.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

heyhey123

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

C

Answer to Question 2

C





 

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library